Paolo Tarantino, Vivian Saykaly Visiting Professor in Medical Oncology at McGill University Health Centre, Clinical Research Fellow at Dana-Farber Cancer Institute, Research Fellow at Harvard Medical School, shared on X:
”Oncology research has never moved so quickly: today we understand tumors like never before and are taking increasingly rapid steps toward truly personalized therapies.
It was a real thrill to share this world with Francesco Costa, among clinical trials, innovation, and the way research can concretely change people’s lives.
It’s all in Wilson.
Listen on the Post app, with an excerpt on Spotify.”
Paolo Tarantino was recognized among OncoDaily’s The 100 Most Influential People in Breast Oncology in 2024, highlighting his contributions to the field of oncology.
Nominations for 100 Influential People in Oncology 2026 are now open, recognizing leaders, researchers, clinicians, innovators, advocates, and other individuals making a meaningful impact on oncology and cancer care.
Don’t miss the opportunity to nominate yourself, a colleague, or someone whose contributions deserve to be recognized.
Submit your nomination by September 15: 100 Influential People in Oncology 2026 – Nominations are Open!
You can also read: ctDNA During Neoadjuvant Therapy: Toward Real-Time Risk Stratification in Early Breast Cancer
